Asterand subsidiary partners with Japanese pharmaceutical firm

Thursday, March 25, 2010 | Source: metromode
Asterand continues to spread its wings as the bio-tech research firm and its subsidiaries lock down more partnerships.

The Detroit-based firm's subsidiary, BioSeek, has agreed to a partnership with Japanese-based Ono Pharmaceutical. Both have signed a three-year drug discovery collaboration agreement.

The plan allows BioSeek to apply its proprietary BioMAP platform on a specific drug target class designated by Ono. Put simply, the agreement allows the firm to use Ono's research to continue developing drugs and parts of future drugs. BioSeek will receive research funding as it hits certain milestones while Ono will keep the rights to develop and sell the pharmaceutical products discovered through the collaboration.

BioSeek's BioMAP Systems concentrates on primary cell-based models of human disease biology, designed to replicate the intricate cell and pathway interactions as they are observed in human pharmacology and toxicology. This can provide insight into properties of compounds, such as on- and off-target effects and dose responses in humans.

Asterand is the leading global supplier of human tissue samples and human tissue-based research services to drug discovery scientists. It is the main tenant in the TechTown business incubator in Detroit's New Center neighborhood.

Source: Asterand
Writer: Jon Zemke
Enjoy this story? Sign up for free solutions-based reporting in your inbox each week.

Related Tags

Biotechnology, Wayne County 

Recommended Content

Related Company

  • Asterand, PLC
    440 Burroughs - Tech One Suite 501
    Detroit, MI 48202-3420 Website
    Asterand is the leading supplier for high quality human tissue-based services supporting drug discovery research.
Sponsored By
Regions
Focus Areas
Copyright © Issue Media Group. All rights reserved.